A detailed history of Lri Investments, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lri Investments, LLC holds 3,306 shares of LLY stock, worth $2.57 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
3,306
Previous 2,250 46.93%
Holding current value
$2.57 Million
Previous $2.04 Billion 27.61%
% of portfolio
0.25%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$772.14 - $960.02 $815,379 - $1.01 Million
1,056 Added 46.93%
3,306 $2.6 Billion
Q2 2024

Jul 24, 2024

BUY
$724.87 - $909.04 $1.56 Million - $1.95 Million
2,146 Added 2063.46%
2,250 $2.04 Billion
Q1 2024

May 21, 2024

SELL
$592.2 - $792.28 $1.3 Million - $1.74 Million
-2,190 Reduced 95.47%
104 $80.9 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $1.36 Million - $1.82 Million
2,294 New
2,294 $1.74 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lri Investments, LLC Portfolio

Follow Lri Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lri Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lri Investments, LLC with notifications on news.